Binding mode analysis between membrane dipeptidase and its substrates

Molecular Simulation

Volumn 33, Issue 6, 2007, Pages 495-503

  Kim, M ^a   Kim, J ^a   Jung, E ^a   Choi, K ^b   Shin, J M ^c   Kang, S K ^d   Kim, M K ^d   Choi, Y J ^d   Choi, S H ^a  

^a Insilicotech Co Ltd   (South Korea)

^b Korea University   (South Korea)

^c SBScience Co Ltd   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

Cilastatin; Docking; Membrane dipeptidase (MDP); Pharmacophore; Virtual screening

Indexed keywords

CRYSTAL STRUCTURE; ENZYMES; LIGANDS; SUBSTRATES;

CILASTATIN; MEMBRANE DIPEPTIDASE (MDP); PHARMACOPHORE; VIRTUAL SCREENING;

BINDING ENERGY;

EID: 34548139739     PISSN: 08927022     EISSN: 10290435     Source Type: Journal    
DOI: 10.1080/08927020701236763     Document Type: Article

References (32)

1. S. Keynan, N.M. Hooper, A.J. Turner. Zinc Metalloproteases in Health and Disease, Taylor & Francis, London (1996).
2. I.J. White, J. Lawson, C.H. Williams, N.M. Hooper. This enzyme is also referred to as leukotriene-D4 hydrolase. Anal. Biochem., 268, 245 (1999).
3. D. Rajotte, E.J. Ruoslahti. Membrane dipeptidase is the receptor for a lung-targeting peptide identified by in vivo phage display. J. Biol. Chem., 274, 11593 (1999).
4. B.J. Campbell. Renal dipeptidase. Methods Enzymol., 19, 722 (1970).
5. D.J. Armstrong, S.K. Mukhopadhyay, B.J. Campbell. Physicochemical characterization of renal dipeptidase. Biochemistry, 13, 1745 (1974).
6. H. Kropp, J.G. Sundelof, R. Hajdu, F.M. Kahan. The tight binding and reversibility features have allowed cilastatin to be exploited in purification of MDP by affinity chromatography. Antimicrob. Agents Chemother., 22, 62 (1982).
7. D.W. Graham, W.T. Ashton, L. Barash, J.E. Brown, R.D. Brown, L.F. Canning, A. Chen, J.P. Springer, E.F. Rogers. Inhibition of the mammalian β-lactamase renal dipeptidase (dehydropeptidase-I) by Z-2-(acylamino)-3- substituted-propenoic acids. J. Med. Chem., 30, 1074 (1987).
8. H. Adachi, Y. Tawaragi, C. Inuzuka, I. Kubota, M. Tsujimoto, T. Nishihara, H. Nakazato. Primary structure of human microsomal dipeptidase deduced from molecular cloning. J. Biol. Chem., 265, 3992 (1990).
9. B.J. Campbell, Y.C. Lin, R. V. Davis, E. Ballew. The purification and properties of a particulate renal dipeptidase. Biochim. Biophys. Acta, 118, 371 (1966).
10. R. Pasqualini, E. Ruoslahti. Organ targeting in vivo using phage display peptide libraries. Nature, 380, 364 (1996).
11. D. Rajotte, W. Arap, M. Hagedorn, E. Koivunen, R. Pasqualini, E. Ruoslahti. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J. Clin. Invest., 102, 430 (1998).
12. W. Arap, R. Pasqualini, E. Ruoslahti. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science, 279, 377 (1998).
13. Y. Nitanai, Y. Satow, H. Adachi, M. Tsujimoto. Crystallization and preliminary X-ray investigation of a glycoprotein, human renal dipeptidase. J. Cryst. Growth, 168, 280 (1996).
14. Y. Nitanai, Y. Satow, H. Adachi, M. Tsujimoto. Crystal structure of human renal dipeptidase involved in β-lactam hydrolysis. J. Mol. Biol., 321, 177 (2002).
15. T.P. Smyth, J.G. Wall, Y. Nitanai. A substrate variant as a high-affinity, reversible inhibitor: insight from the X-ray structure of cilastatin bound to membrane dipeptidase. Bioorg. Med. Chem., 11, 991 (2003).
16. Catalyst, Version 4.11, Accelrys, Inc., San Diego (2005).
17. C.M. Venkatachalam, X. Jiang, T. Oldfield, M. Waldman. LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. J. Mol. Graph. Model., 21, 289 (2003).
18. Discovery Studio, Version 1.5, Accelrys, Inc., San Diego (2006).
19. J. Kirchmair, C. Laggner, G. Wolber, T. Langer. Comparative analysis of protein-bound ligand conformations with respect to catalyst's conformational space subsampling algorithms. J. Chem. Inf. Model., 45, 422 (2005).
20. D. Goldfarb. A family of variable-metric methods derived by variational means. Math. Comput., 24, 23 (1970).
21. C.G. Broyden. The convergence of a class of double-rank minimization algorithms: 2. The new algorithm. J. Inst. Math. Appl., 6, 222 (1970).
22. J.D. Foley, A. Van Dam. Fundamentals of interactive computer graphics, Addison-Wesley, MA (1982).
23. D.F. Rogers. Procedural elements for computer graphics, McGraw-Hill, New York (1985).
24. K. Baldridge, R. Fine, A. Hagler. The effects of solvent screening in quantum mechanical calculations in protein systems. J. Comput. Chem., 15, 1217 (1994).
25. M. Waldman, A.T. Hagler. New combining rules for rare gas van der Waals parameters. J. Comput. Chem., 14, 1077 (2003).
26. A. Krammer, P.D. Kirchhoff, X. Jiang, C.M. Venkatachalam, M. Waldman. LigScore: a novel scoring function for predicting binding affinities. J. Mol. Graph. Model., 23, 395 (2005).
27. I. Muegge, Y.C. Martin. A general and fast scoring function for protein-ligand interactions: a simplified potential approach. J. Med. Chem., 42, 791 (1999).
28. H.J. Böhm. The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure. J. Comput. Aided Mol. Des., 8, 243 (1994).
29. S. Keynan, N.M. Hooper, A.J. Turner. Directed mutagenesis of pig renal membrane dipeptidase His219 is critical but DHXXH motif is no essential for zinc binding or catalytic activity. FEBS Lett., 349, 50 (1994).
30. T.P. Smyth. Substrate variants versus transition state analogues as noncovalent reversible enzyme inhibitors. Bioorg. Med. Chem., 12, 4081 (2004).
31. Y. Kera, Z. Liu, T. Matsumoto, Y. Sorimachi, H. Nagasaki, R. Yamada. Rat and human membrane dipeptidase: tissue distribution and developmental changes. Comp. Biochem. Phys. B, 123, 53 (1999).
32. T. Watanabe, Y. Kera, T. Matsumoto, R. Yamada. Purification and kinetic properties of a D-amino-acid peptide hydrolyzing enzyme from pig kidney cortex and its tentative identification with renal membrane dipeptidase. Biochim. Biophys. Acta, 1298, 109 (1996).